PI
AVXL icon

PHH Investments’s Anavex Life Sciences AVXL Stock Holding History

PHH Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,071
Closed -$83K – 82
2019
Q1 		$83K Sell
27,071
-16,489
-38% -$39.4K 0.02% 81
2018
Q4 		$68K Buy
43,560
+22,727
+109% +$51.6K 0.02% 80
2018
Q3 		$57K Sell
20,833
-19,067
-48% -$53.8K 0.02% 79
2018
Q2 		$105K Buy
39,900
+25,100
+170% +$70.1K 0.03% 75
2018
Q1 		$41K Buy
+14,800
New +$41.8K 0.01% 79

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PHH Investments's AVXL Position: Q2 2019 in Review

PHH Investments sold out of Anavex Life Sciences (AVXL) in Q2 2019, closing a stake of 27,071 shares — an estimated $83K sold.

PHH Investments first reported a position in AVXL in Q1 2018 and held it in 5 quarters. The position peaked at $105K in Q2 2018. 59 funds tracked by Wall St. Rank hold AVXL as of Q2 2019.

  • PHH Investments reported no remaining Anavex Life Sciences position as of Q2 2019 after selling out during the quarter.
  • PHH Investments sold 27,071 Anavex Life Sciences shares in Q2 2019, an estimated $83K.
  • PHH Investments first reported a position in Anavex Life Sciences in Q1 2018 and held it in 5 quarters.
  • PHH Investments's Anavex Life Sciences position peaked at $105K in Q2 2018.
  • 59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2019.

Based on PHH Investments's 13F filing for Q2 2019, filed 14 Aug 2019.